Advanced search
Publication Cover
Clinical Toxicology Volume 58, 2020 - Issue 12
Submit an article Journal homepage
417
Views
8
CrossRef citations to date
0
Altmetric
Original Scientific Contributions

Does cannabidiol induce cannabinoid hyperemesis syndrome?

Hervé Laborde-CasterotCentre AntiPoison et de Toxicovigilance de Paris – Fédération de toxicologie de l’APHP (FeTox), Hôpital Fernand-Widal - APHP, Paris, France
,
Islam Amine LarabiLaboratoire de Pharmacologie-Toxicologie, Centre Hospitalier Universitaire Raymond Poincaré - APHP, Garches, France;Plateforme de Spectrométrie de Masse MassSpecLab, INSERM UMR 1173, UFR des Sciences de la Santé Simone Veil, Université Versailles Saint-Quentin, Montigny le Bretonneux, France
,
Laurène DufayetCentre AntiPoison et de Toxicovigilance de Paris – Fédération de toxicologie de l’APHP (FeTox), Hôpital Fernand-Widal - APHP, Paris, France;Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM UMR-S 1144, Faculté de Pharmacie, Paris, France;UFR de médecine, Université de Paris, Paris, France
,
Isabelle EttingLaboratoire de Pharmacologie-Toxicologie, Centre Hospitalier Universitaire Raymond Poincaré - APHP, Garches, France
,
Jean-Claude AlvarezLaboratoire de Pharmacologie-Toxicologie, Centre Hospitalier Universitaire Raymond Poincaré - APHP, Garches, France;Plateforme de Spectrométrie de Masse MassSpecLab, INSERM UMR 1173, UFR des Sciences de la Santé Simone Veil, Université Versailles Saint-Quentin, Montigny le Bretonneux, France
&
Dominique VodovarCentre AntiPoison et de Toxicovigilance de Paris – Fédération de toxicologie de l’APHP (FeTox), Hôpital Fernand-Widal - APHP, Paris, France;Optimisation Thérapeutique en Neuropsychopharmacologie, INSERM UMR-S 1144, Faculté de Pharmacie, Paris, France;Urgences Médico-Judiciaires, Hôpital Hôtel Dieu - APHP, Paris, FranceCorrespondence[email protected]
Pages 1351-1352 | Received 06 Jan 2020, Accepted 20 Feb 2020, Published online: 12 Mar 2020

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Guillermo Burillo-Putze, John R. Richards, Consuelo Rodríguez-Jiménez & Alejandro Sanchez-Agüera. (2022) Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature. Expert Opinion on Pharmacotherapy 23:6, pages 693-702.
Read now

Articles from other publishers (7)

William L. Hasler, Thangam Venkatesan & David J. Levinthal. 2022. Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis. Cyclic Vomiting Syndrome and Cannabinoid Hyperemesis 255 284 .
Brandon A. Berger, Uwe Stolz, Jonathan Colvin & Edward J. Otten. (2021) The authors respond: “Cannabidiol-induced toxicity: Who is the culprit?”. The American Journal of Emergency Medicine 47, pages 286.
Crossref
Dominique Vodovar, Weniko Caré, Laurène Dufayet & Anne Batisse. (2021) Cannabidiol-induced toxicity: who is the culprit?. The American Journal of Emergency Medicine 47, pages 284-285.
Crossref
Julie Weiss, Romain Torrents, Baptiste Verhamme, Antoine Roch, Pierre Lazerges, Maeva Jego, Pierre Michelet & Nicolas Simon. (2020) Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort. Fundamental & Clinical Pharmacology 35:1, pages 186-191.
Crossref
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, Frauke Herbi, Yvonne Zerbe, Verena Bock, Tabata Rajcic de Rezende, Stephan G. Walch & Constanze Sproll. (2023) Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Research 8, pages 1394.
Crossref
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, Frauke Herbi, Yvonne Zerbe, Verena Bock, Tabata Rajcic de Rezende, Stephan G. Walch & Constanze Sproll. (2022) Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Research 8, pages 1394.
Crossref
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, Frauke Herbi, Yvonne Zerbe, Verena Bock, Tabata Rajcic de Rezende, Stephan G. Walch & Constanze Sproll. (2021) Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Research 8, pages 1394.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.